These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25011580)

  • 1. Attenuated psychosis syndrome: don't jump the gun.
    Nelson B
    Psychopathology; 2014; 47(5):292-6. PubMed ID: 25011580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated psychosis syndrome: need for debate on a new disorder.
    Carpenter WT
    Psychopathology; 2014; 47(5):287-91. PubMed ID: 25060627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should attenuated psychosis syndrome be included in DSM-5?
    Fusar-Poli P; Yung AR
    Lancet; 2012 Feb; 379(9816):591-2. PubMed ID: 22340290
    [No Abstract]   [Full Text] [Related]  

  • 4. [Attenuated psychosis syndrome: A new diagnostic category for further study in DSM-5].
    Samiotakis G; Kollias C; Lazaratou H; Anagnostopoulos D; Kontaxakis V
    Psychiatriki; 2017; 28(2):120-130. PubMed ID: 28686559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic.
    Gaudiano BA; Zimmerman M
    J Clin Psychiatry; 2013 Feb; 74(2):149-55. PubMed ID: 23146173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations.
    Schultze-Lutter F; Renner F; Paruch J; Julkowski D; Klosterkötter J; Ruhrmann S
    Psychopathology; 2014; 47(3):194-201. PubMed ID: 24192655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication.
    Peralta V; Campos MS; de Jalon EG; Cuesta MJ
    Schizophr Res; 2010 May; 118(1-3):168-75. PubMed ID: 20071147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conceptual issues in the classification of psychosis.
    Phillips J
    Curr Opin Psychiatry; 2013 Mar; 26(2):214-8. PubMed ID: 23370275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practitioner perceptions of attenuated psychosis syndrome.
    Jacobs E; Kline E; Schiffman J
    Schizophr Res; 2011 Sep; 131(1-3):24-30. PubMed ID: 21764261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.
    Salazar de Pablo G; Catalan A; Fusar-Poli P
    JAMA Psychiatry; 2020 Mar; 77(3):311-320. PubMed ID: 31746950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should attenuated psychosis syndrome be a DSM-5 diagnosis?
    Carpenter WT; van Os J
    Am J Psychiatry; 2011 May; 168(5):460-3. PubMed ID: 21536700
    [No Abstract]   [Full Text] [Related]  

  • 13. Attenuated psychosis syndrome: ready for DSM-5.1?
    Fusar-Poli P; Carpenter WT; Woods SW; McGlashan TH
    Annu Rev Clin Psychol; 2014; 10():155-92. PubMed ID: 24471375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics in Children and Adolescents at Clinical High Risk for Psychosis.
    Raballo A; Poletti M; Preti A
    J Am Acad Child Adolesc Psychiatry; 2022 Mar; 61(3):354-356. PubMed ID: 34224839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the tendencies of community practitioners who actively practice in child and adolescent psychiatry to diagnose and treat DSM-5 attenuated psychotic syndrome.
    Yilmaz Kafali H; Solerdelcoll M; Vujinovic L; Martsenkovskyi D; Awhangansi S; Noel C; Bora E; Arango C
    Eur Child Adolesc Psychiatry; 2022 Oct; 31(10):1635-1644. PubMed ID: 34669043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Values and DSM-5: looking at the debate on attenuated psychosis syndrome.
    Gonçalves AM; Dantas Cde R; Banzato CE
    BMC Med Ethics; 2016 Jan; 17():7. PubMed ID: 26791783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study.
    Schultze-Lutter F; Michel C; Ruhrmann S; Schimmelmann BG
    Schizophr Bull; 2014 Nov; 40(6):1499-508. PubMed ID: 24353096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DSM-5 proposal for attenuated psychosis syndrome: a history.
    Zachar P; First MB; Kendler KS
    Psychol Med; 2020 Apr; 50(6):920-926. PubMed ID: 32234093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognizing and responding to early psychosis: a qualitative analysis of individual narratives.
    Judge AM; Estroff SE; Perkins DO; Penn DL
    Psychiatr Serv; 2008 Jan; 59(1):96-9. PubMed ID: 18182546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders.
    Gerstenberg M; Hauser M; Al-Jadiri A; Sheridan EM; Kishimoto T; Borenstein Y; Vernal DL; David L; Saito E; Landers SE; Carella M; Singh S; Carbon M; Jiménez-Fernández S; Birnbaum ML; Auther A; Carrión RE; Cornblatt BA; Kane JM; Walitza S; Correll CU
    J Clin Psychiatry; 2015 Nov; 76(11):e1449-58. PubMed ID: 26646040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.